Cutler Group LP Novavax Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Novavax Inc stock. As of the latest transaction made, Cutler Group LP holds 500 shares of NVAX stock, worth $4,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 1,100 54.55%

Holding current value

$4,255

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$3.76 - $6.02 $2,256 - $3,611	-600 Reduced 54.55%	500 $2,000
Q4 2023 Jan 18, 2024	SELL	$4.8 - $7.67 $3,374 - $5,392	-703 Reduced 38.99%	1,100 $5,000
Q3 2023 Nov 07, 2023	BUY	$6.81 - $9.74 $4,787 - $6,847	703 Added 63.91%	1,803 $13,000
Q2 2023 Jul 18, 2023	SELL	$6.67 - $9.52 $1,334 - $1,904	-200 Reduced 15.38%	1,100 $8,000
Q1 2023 May 01, 2023	BUY	$5.76 - $12.48 $7,488 - $16,224	1,300 New	1,300 $9,000
Q3 2022 Oct 25, 2022	SELL	$18.2 - $76.12 $463,426 - $1.94 Million	-25,463 Reduced 87.07%	3,780 $68,000
Q2 2022 Aug 04, 2022	BUY	$36.28 - $75.29 $602,864 - $1.25 Million	16,617 Added 131.61%	29,243 $1.5 Million
Q1 2022 Apr 14, 2022	SELL	$69.73 - $142.9 $727,423 - $1.49 Million	-10,432 Reduced 45.24%	12,626 $929,000
Q4 2021 Jan 18, 2022	BUY	$134.56 - $217.97 $1.11 Million - $1.8 Million	8,258 Added 55.8%	23,058 $3.3 Million
Q3 2021 Oct 26, 2021	SELL	$177.8 - $270.58 $71,120 - $108,232	-400 Reduced 2.63%	14,800 $3.07 Million
Q2 2021 Jul 19, 2021	BUY	$121.0 - $257.67 $423,500 - $901,845	3,500 Added 29.91%	15,200 $3.23 Million
Q1 2021 Apr 26, 2021	BUY	$112.98 - $319.93 $72,307 - $204,755	640 Added 5.79%	11,700 $2.12 Million
Q4 2020 Jan 21, 2021	SELL	$78.74 - $139.5 $614,250 - $1.09 Million	-7,801 Reduced 41.36%	11,060 $1.23 Million
Q3 2020 Oct 27, 2020	SELL	$79.44 - $178.51 $344,690 - $774,554	-4,339 Reduced 18.7%	18,861 $2.04 Million
Q2 2020 Jul 22, 2020	BUY	$13.86 - $83.61 $299,376 - $1.81 Million	21,600 Added 1350.0%	23,200 $1.93 Million
Q4 2019 Feb 06, 2020	SELL	$3.69 - $5.22 $2,952 - $4,176	-800 Reduced 33.33%	1,600 $6,000
Q3 2019 Oct 28, 2019	BUY	$4.02 - $7.84 $9,647 - $18,816	2,400 New	2,400 $12,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account